US EditionNTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit
- A securities lawsuit was filed against TransMedics Group, Inc., ticker TMDX.
- The lawsuit follows accusations that TransMedics misappropriated funds and deceived investors.
- This class action includes investors who purchased securities between February 28, 2023, and January 10, 2025.
- TransMedics shares fell $2.18 on February 22, 2024; a report caused a $3.74 drop on January 10, 2025.
- Investors seeking lead plaintiff status have until April 15, 2025; Berger Montague PC advises them.
62 Articles
62 Articles
NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, April 13, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intellia Therapeutics, Inc. (NASDAQ: NTLA) between July 30, 2024 and January 8, 2025, both dates inclusive (the "Class Period"),…
ALAR Investors Have the Opportunity to Lead the Alarum Technologies Securities Fraud Lawsuit ...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Alarum To Contact Him Directly To Discuss Their Options
Johnson City Press
TUESDAY DEADLINE: Berger Montague Advises TransMedics Group (NASDAQ: TMDX) Investors to Inquire About a Securities Fraud Class Action by April 15, 2025
PHILADELPHIA, April 12, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) on behalf of purchasers of TransMedics securities between February 28,…
EU Investors Have the Opportunity to Lead the enCore Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In enCore To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in enCore between March 28, 2024 and March 2, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
